EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors

Lu Zhang, Yajun Yang, Ying Yang iD, Zhiyan Xiao iD

Molecules · 2024

DOI: 10.3390/molecules29051096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Lu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences an…. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Metalloproteins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metalloenzymes are ubiquitously present in the human body and are relevant to a variety of diseases. However, the development of metalloenzyme inhibitors is limited by low specificity and poor drug-likeness associated with metal-binding fragments (MBFs). A generalized drug discovery strategy was established, which is characterized by the property characterization of zinc-dependent metalloenzyme inhibitors (ZnMIs). Fifteen potential Zn2+-binding fragments (ZnBFs) were identified, and a customized pharmacophore feature was defined based on these ZnBFs. The customized feature was set as a required feature and applied to a search for novel inhibitors for histone deacetylase 1 (HDAC1). Ten potential HDAC1 inhibitors were recognized, and one of them (compound 9) was a known potent HDAC1 inhibitor. The results demonstrated the effectiveness of our strategy to identify novel inhibitors for zinc-dependent metalloenzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase InhibitorsMetalloproteinsHumansDrug DiscoveryZincHistone Deacetylase 1

Stichwörter der Autor:innen

histone deacetylasemetal-binding fragmentsmetalloenzyme inhibitorsproperty characterizationvirtual screening

Substanzen

Histone Deacetylase InhibitorsMetalloproteinsZincHistone Deacetylase 1HDAC1 protein, human

Autor:innen und Institutionen

  • Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
  • Department of Toxicology, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China.
  • State Key Laboratory of Digestive Health, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Ying Yang, Zhiyan Xiao

Förderung

  • Chinese Academy of Medical Sciences & Peking Union Medical College
  • CAMS Innovation Fund for Medical Sciences

Zitieren

APA

Zhang, L., Yang, Y., Yang, Y., & Xiao, Z. (2024). Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors. Molecules. https://doi.org/10.3390/molecules29051096

Vancouver

Zhang L, Yang Y, Yang Y, Xiao Z. Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors. Molecules. 2024. doi:10.3390/molecules29051096

BibTeX
@article{Zhang2024,
  author = {Zhang, Lu and Yang, Yajun and Yang, Ying and Xiao, Zhiyan},
  title = {Discovery of Novel Metalloenzyme Inhibitors Based on Property Characterization: Strategy and Application for HDAC1 Inhibitors},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29051096}
}
Kostenlos starten →